GSS EU Science Funding Gateway

Proposals should provide innovative approaches with the aim to diversify and accelerate the global pandemic preparedness research and development pipeline for emerging and re-emerging viral infections, and to strengthen the role of the EU in therapeutic research and development, and therefore contributing to the work of the European Health Emergency Preparedness and Response Authority (HERA).

Proposals should address several of the following areas:

• Identification of key antigenic targets for the priority pathogens as mentioned above.
• Improvement or, if necessary, establishment of animal models for the testing of vaccine candidates where alternative models are not available.
• Characterisation of the immunogenicity of antigenic targets in appropriate animal or alternative models and in pre-clinical tests.
• Inclusion, if possible, of proof-of-concept studies in humans of the vaccine candidate.

Applicants envisaging to include clinical studies should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.